Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 4

1(12.5%)

8Total

N/A(7)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06493812Not ApplicableRecruiting

Comparison of Clinical Value in the Use of the Fascia Lata and Temporal Muscle Fascia in the Reconstruction of the Dura in the Sellar Region

Role: lead

NCT04940338Phase 4Completed

PCME Prevention in Patients With NPDR

Role: lead

NCT04891588Not ApplicableUnknown

Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD

Role: lead

NCT03841474Not ApplicableUnknown

The Recovery of Cardiovascular Patients With Depression

Role: lead

NCT04335916Unknown

Survey on Pre-ECT Evaluation and ECT Application

Role: lead

NCT02732145Not ApplicableCompleted

Diagnostic Accuracy of "Three Rings Vulvoscopy" for Detection of Vulvar Dermatosis

Role: collaborator

NCT03862209Not ApplicableUnknown

Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health (RECOVER-E) Croatia

Role: lead

NCT03822247Not ApplicableUnknown

Evaluation of Multidisciplinary Recovery After Surgery Program in Orthopedics and Traumatology

Role: lead

NCT02033213Not ApplicableCompleted

Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial

Role: lead

All 9 trials loaded